KALV R&D Expenses
Kalvista Pharmaceuticals Inc · R&D Expenses
KALV R&D Expenses
Latest reported$8.85Mperiod ending
KALV Quarterly R&D Expenses ($1.12M → $8.85M)
Quarterly R&D Expenses
High-resolution chart · PNG
KALV r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 8,849,500 | |
| 12,420,000 | |
| 11,993,000 | |
| 15,162,000 | |
| 15,891,000 | |
| 12,594,000 | |
| 16,610,000 | |
| 26,614,000 | |
| 25,248,000 | |
| 22,523,000 | |
| 19,089,000 | |
| 19,307,000 | |
| 23,951,000 | |
| 20,063,000 | |
| 18,077,000 | |
| 18,186,000 | |
| 19,213,000 | |
| 19,738,000 | |
| 17,546,000 | |
| 13,669,000 | |
| 11,877,000 | |
| 9,097,000 | |
| 9,148,000 | |
| 11,165,000 | |
| 9,485,000 | |
| 11,233,000 | |
| 9,789,000 | |
| 9,686,000 | |
| 11,139,000 | |
| 7,650,000 | |
| 7,876,000 | |
| 8,356,000 | |
| 5,852,000 | |
| 4,548,000 | |
| 4,361,000 | |
| 3,476,000 | |
| 2,996,000 | |
| 3,339,000 | |
| 332,000 | |
| 332,000 | |
| 3,532,000 | |
| 4,260,000 | |
| 3,533,000 | |
| 4,504,000 | |
| 3,902,000 | |
| 3,031,000 | |
| 2,088,000 | |
| 1,750,000 | |
| 1,425,000 | |
| 1,116,000 |